EDAP TMS France SA

For more than 25 years, EDAP TMS (NASDAQ : EDAP) has been dedicated to providing minimally-invasive ultrasound therapeutic solutions to urologists around the world. Present at the local level through an extensive network of subsidiaries, the company tailors high standard services for its partners. 

Through on-going and consistent R&D investment and partnerships with world leading medical research institutions, EDAP TMS manages to internally develop and patent innovative technologies and features for its ranges of products.

With Ablatherm®, EDAP TMS is the world leader in HIFU and introduced the first device to receive CE marking for localized prostate cancer treatment. The company is also developing this technology for the potential treatment of other types of tumors.

Also, with the Sonolith® range, EDAP TMS is a pioneer and a key player of the ESWL market with the introduction of modular lithotripters and the patented Electroconductive® technology.

EDAP TMS focuses daily on delivering technologies that guarantee reproducible positive outcomes, low side effects and preserved quality of life. As clinically proven therapeutic options, EDAP TMS’ devices are highly trusted among leading urologists across the world.

French Offices

EDAP TMS France SA
Parc d'activités La Poudrette-Lamartine
4, rue du Dauphiné
69120 Vaulx-en-Velin - France
Telephone: +33 (0) 4 72 15 31 50
Fax: +33 (0) 4 72 15 31 51

French Officers

Marc Oczachowski, President & General Manager
Eric Soyer, Chief Financial Officer
Emmanuel Blanc, Chief Technology Officer
Jean-Christophe Dozoul, Chief Procurement Officer
John Rewcastle, Medical Director
Jérôme Lavaure, Marketing & Application Director
Bruno Pagès, Quality & Regulatory Affairs Director
Pierre Reboul, France Sales Director
Jean-François Bachelard, North Europe & Russia Sales Director
Marc Perry, United Kingdom Sales Director